Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

Diseases of autoimmune connective tissues occur in such a way by a preclinical asymptomatic self-immunity. Type I interferons have a crucial role in the progression of established autoimmune diseases. The cellular source and regulation of disease initiation of these cytokines are unclear, but dendritic cells of plasmacytoids have been thought to contribute to the production of excessive interferon type I. Here, we show that in Preclinical autoimmunity and systemic systemic erythematosus established, the dendritic cells of plasmacytoids are not efficient cells, have lost the capacity of the production of cytokine to toll mediation and do not induce the activation of the T cell, independent of The activity of the disease and blood interferon signature. In addition, the dendritic cells of plasmacytoids have an indicative transcriptional signature of cell stress and senescence accompanied by an increase in telomere erosion.

In preclinical self-immunity, we show a marked enrichment of an interferon signature in the skin without infiltrating immune cells, but with interferon-κ production by keratinocytes. In conclusion, non-hematopoietic cellular sources, rather than dendritic cells of plasmacytoids, are responsible for interferon production before clinical self-immunity. The immune system is responsible for identifying malignant cells to eliminate or prevent the propagation of cancer. This involves a complex orchestration of many types of immune cells that together recognize different aspects of the transformation and growth of the tumor. In response, tumors have developed mechanisms to circumvent the immune attack. Type I interferons (IFN-IS) are a class of preflammatory cytokines produced in response to viruses and other environmental stressors.

The IFN-is also emerge as essential pilots of antitumor immunity, stimulating the immune cell capacity for the elimination of tumor cells. However, a more complex role for IFN-is produced, as prolonged stimulation can promote information feedback mechanisms that contribute to immune depletion and other deleterious effects that directly or indirectly or indirectly the cancer cells. to escape immune clearance. We examine the fundamental and opposing functions of the IFN – can modulate the growth of the tumor and the impact of immune function and finally the way these functions can be exploited for the design of new cancer treatments.

The key roles of interferon lambda in human molecular defense against respiratory viral infections

Interferons (IFN) are crucial for the innate immune response. A little over two decades two decades ago, a new type of IFN has been discovered: IFN Lambda (IFN type III). As the other IFN, the IFN type III displays the antiviral activity against a wide variety of infections, they induce the expression of antiviral genes and stimulated by interferon (MX1, OAS, IFITM1) and have activities immunodolory makers that shape adaptive immune responses.

Unlike the other IFN, the IFN type III signal through distinct receptors is limited to a few types of cells, mainly mucous epithelial cells. As a result of their larger and more sustainable production in the nasal and respiratory tissues, they can determine the result of respiratory infections. This examination focuses on the role of IFN-λ in the pathogenesis of respiratory viral infections, with the flu as a great example. The influenza virus is a major public health problem, causing up half a million fatal infections each year. In addition, the virus was the cause of four pandemics in the last century.

Although IFN-λ is increasingly tested in antiviral therapy, they can have a negative influence on the recovery of epithelial tissues and increase the risk of secondary bacterial infections. Therefore, the expression IFN-λ deserves increased monitoring as a key factor in the immune response of the host to infection.

 Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity

 

An observational study of the real world of drug use and clinical outcomes of antivirals of direct action and interferon therapy for the treatment of hepatitis C in Taiwan

Objective: In this study, we have studied the use of direct action antivirals (DAAS), medical expenses and clinical outcomes since the initiation of national health insurance coverage in Taiwan.

Methods: It was a retrospective observation study. We have obtained the National Database on Taiwan Health Insurance database in 2017. Patients diagnosed with hepatitis C with at least two visits to physicians or hospitalization were included in the study. Cases have been divided into three groups based on the type of treatment: Traditional treatment (interferon, inf), new drug treatment (DAA) and INF-Experienced (INF followed by DAAS). We compared the distributions of various cases based on individual demographic variables, hospital types and comorbidities. Trends in medical expenses by type of treatment have been estimated. We also analyzed clinical outcomes, including rehospitalization and hepatic function disorders, using a survival analysis method.

Results: Among patients with hepatitis C, the DAA Group had a significantly higher proportion of women, a more meaningful average age and a greater seriousness of the disease than Group INF. The growth rate of medical expenses was significantly lower than the DAA group. In addition, compared to the INF Group, the DAA Group and the infented group have had significantly lower rehospitalization rates and that the DAA group had a significantly lower risk of liver function disorders. In addition, plus a patient received a form of treatment, the lowest was their chance of rehospitalization and hepatic function disorders.

Rat, Pegylated Rat Leptin Recombinant Protein

PROTP50596-1 20 ug
EUR 317
Description: Mono-Pegylated Leptin Rat Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 147 amino acids and an additional Ala at N-terminus having a molecular mass of 35.6 kDa (with 20 kDa PEG) as determined by mass spectometry. However due to enlarged hydrodymanic volume it runs on the SDS-PAGE as 48 kDa protein and in gel-filtration on Superdex 200 as over 100 kDa protein. Its half-life in circulation after SC injection was over 20 hours. Rat Leptin was purified by proprietary chromatographic techniques according to Salomon et al (2006) Protein Expression and Purification 47, 128–136 and then pegylated._x000D_

Antibody for Rat HO-1 (Rat)

SPC-207D 0.1mg
EUR 332
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is unconjugated.

Antibody for Rat HO-1 (Rat)

SPC-207D-A390 0.1mg
EUR 379
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 390.

Antibody for Rat HO-1 (Rat)

SPC-207D-A488 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 488.

Antibody for Rat HO-1 (Rat)

SPC-207D-A565 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 565.

Antibody for Rat HO-1 (Rat)

SPC-207D-A594 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 594.

Antibody for Rat HO-1 (Rat)

SPC-207D-A633 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 633.

Antibody for Rat HO-1 (Rat)

SPC-207D-A655 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 655.

Antibody for Rat HO-1 (Rat)

SPC-207D-A680 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 680.

Antibody for Rat HO-1 (Rat)

SPC-207D-A700 0.1mg
EUR 378
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to ATTO 700.

Antibody for Rat HO-1 (Rat)

SPC-207D-ALP 0.1mg
EUR 372
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Alkaline Phosphatase.

Antibody for Rat HO-1 (Rat)

SPC-207D-APC 0.1mg
EUR 377
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to APC .

Antibody for Rat HO-1 (Rat)

SPC-207D-APCCY7 0.1mg
EUR 450
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to APC/Cy7.

Antibody for Rat HO-1 (Rat)

SPC-207D-BI 0.1mg
EUR 374
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Biotin.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY350 0.1mg
EUR 393
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 350.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY405 0.1mg
EUR 381
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 405.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY488 0.1mg
EUR 371
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 488.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY594 0.1mg
EUR 373
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 594.

Antibody for Rat HO-1 (Rat)

SPC-207D-DY633 0.1mg
EUR 368
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Dylight 633.

Antibody for Rat HO-1 (Rat)

SPC-207D-FITC 0.1mg
EUR 370
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to FITC.

Antibody for Rat HO-1 (Rat)

SPC-207D-HRP 0.1mg
EUR 366
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to HRP.

Antibody for Rat HO-1 (Rat)

SPC-207D-P594 0.1mg
EUR 385
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to PE/ATTO 594.

Antibody for Rat HO-1 (Rat)

SPC-207D-PCP 0.1mg
EUR 377
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to PerCP.

Antibody for Rat HO-1 (Rat)

SPC-207D-RPE 0.1mg
EUR 375
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to RPE .

Antibody for Rat HO-1 (Rat)

SPC-207D-STR 0.1mg
EUR 376
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is conjugated to Streptavidin.

Antibody for Rat HO-1 (Rat)

SPC-207S 0.012mg
EUR 65
  • Heme-oxygenase is a ubiquitous enzyme that catalyzes the initial and rate-limiting steps in heme catabolism yielding equimolar amounts of biliverdin, iron and carbon monoxide. Biliverdin is subsequently converted to bilirubin and the free iron is seq
  • Show more
Description: A polyclonal antibody for HO-1 from Mouse | Rat. The antibody is produced in rabbit after immunization with Rat Rat HO-1 without the transmembrane domain (cloned residues 1-262). The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:1000). This HO-1 antibody is unconjugated.

CGRP (rat)

B5061-.5 500 µg
EUR 451

CGRP (rat)

B5061-1 1 mg
EUR 814

Ghrelin (rat)

B5120-1 1 mg
EUR 772

Urocortin (rat)

B5146-.5 500 ?g
EUR 337

Urocortin (rat)

B5146-1 1 mg
EUR 487

Urocortin (rat)

B5146-5 5 mg
EUR 1543

Hemopressin (rat)

B5167-1 1 mg
EUR 502

Secretin (rat)

B5232-1 1 mg
EUR 326

Obestatin (rat)

B5306-1 1 mg
EUR 177

GRF (rat)

H-5440.0500 0.5mg
EUR 563
Description: Sum Formula: C225H361N77O66S; CAS# [86472-71-1] net

GRF (rat)

H-5440.1000 1.0mg
EUR 1034
Description: Sum Formula: C225H361N77O66S; CAS# [86472-71-1] net

Secretin (rat)

H-5498.0001 1.0mg
EUR 563
Description: Sum Formula: C129H216N42O42; CAS# [121028-49-7]

Secretin (rat)

H-5498.0005 5.0mg
EUR 2159
Description: Sum Formula: C129H216N42O42; CAS# [121028-49-7]

Intermedin (rat)

H-6068.0500 0.5mg
EUR 515
Description: Sum Formula: C226H361N75O64S2; CAS# [1816940-00-7] net

Intermedin (rat)

H-6068.1000 1.0mg
EUR 816
Description: Sum Formula: C226H361N75O64S2; CAS# [1816940-00-7] net

Obestatin (rat)

H-6338.0500 0.5mg
EUR 454
Description: Sum Formula: C114H174N34O31; CAS# [869705-22-6] net

Obestatin (rat)

H-6338.1000 1.0mg
EUR 756
Description: Sum Formula: C114H174N34O31; CAS# [869705-22-6] net

Preptin (rat)

H-6572.0100 0.1mg
EUR 151
Description: Sum Formula: C181H268N48O51; CAS# [315197-73-0] net

Preptin (rat)

H-6572.0500 0.5mg
EUR 515
Description: Sum Formula: C181H268N48O51; CAS# [315197-73-0] net

Preptin (rat)

H-6572.1000 1.0mg
EUR 938
Description: Sum Formula: C181H268N48O51; CAS# [315197-73-0] net

Copeptin (rat)

H-6726.0500 0.5mg
EUR 393
Description: Sum Formula: C183H307N57O61; CAS# [86280-64-0] net

Copeptin (rat)

H-6726.1000 1.0mg
EUR 696
Description: Sum Formula: C183H307N57O61; CAS# [86280-64-0] net

Alarin (rat)

H-6762.0500 0.5mg
EUR 231
Description: Sum Formula: C119H199N45O35; CAS# [909409-88-7] net

Alarin (rat)

H-6762.1000 1.0mg
EUR 360
Description: Sum Formula: C119H199N45O35; CAS# [909409-88-7] net

Adrenomedullin (rat)

H-2934.0500 0.5mg
EUR 587
Description: Sum Formula: C242H381N77O75S5; CAS# [161383-47-7] net

Adrenomedullin (rat)

H-2934.1000 1.0mg
EUR 961
Description: Sum Formula: C242H381N77O75S5; CAS# [161383-47-7] net

Calcitonin (rat)

H-3072.0001 1.0mg
EUR 236
Description: Sum Formula: C148H228N40O46S3; CAS# [11118-25-5]

Calcitonin (rat)

H-3072.0005 5.0mg
EUR 853
Description: Sum Formula: C148H228N40O46S3; CAS# [11118-25-5]

Urocortin (rat)

H-3362.0500 0.5mg
EUR 273
Description: Sum Formula: C206H338N62O64; CAS# [171543-83-2] net

Urocortin (rat)

H-3362.1000 1.0mg
EUR 418
Description: Sum Formula: C206H338N62O64; CAS# [171543-83-2] net

Rat HSV

ERH0317 96Tests
EUR 521

Rat HSV

ERH0318 96Tests
EUR 521

Urocortin, rat

HY-P1296 5mg
EUR 1187

EGF, Rat

HY-P7092 50ug
EUR 211

OSM, Rat

HY-P7105 100ug
EUR 1256

CNTF, Rat

HY-P7148 50ug
EUR 497

Leptin, Rat

HY-P7233 50ug
EUR 153

Rat Serum

abx098267-10ml 10 ml
EUR 272
  • Shipped within 5-10 working days.

Amylin, rat

5-00650 0.4 x 5mg Ask for price

Calcitonin, rat

5-00903 4 x 1mg Ask for price

Galanin, rat

5-01177 4 x 1mg Ask for price

Ghrelin (Rat)

5-01201 4 x 1mg Ask for price

GHRF, rat

5-01204 4 x 1mg Ask for price

Intermedin (rat)

5-01405 4 x 1mg Ask for price

Necrofibrin, rat

5-01585 4 x 5mg Ask for price

PHI, rat

5-01758 4 x 1mg Ask for price

Pneumadin (rat)

5-01780 4 x 5mg Ask for price

Secretin, rat

5-01916 4 x 1mg Ask for price

Urocortin, rat

5-02053 4 x 1mg Ask for price

Rat IgM

31C-CH1213 1 mg
EUR 377
Description: Purified Rat IgM

Rat Fibronectin

7-05200 20µg Ask for price

Rat Fibronectin

7-05201 100µg Ask for price

Rat Fibronectin

7-05202 1mg Ask for price

Rat Cardiomyocytes

PC35134 P0 Rat - Whole Heart Dissociated Cells X2
EUR 1419

GDNF (Rat)

PR15008 50 ug
EUR 1277

Leptin-Rat

PR27100 200 ug
EUR 191

Rat IgG

M1101-100
EUR 153

Rat IgG

M1101-1000
EUR 370

Rat(H2b)

QY-E11674 96T
EUR 374

Rat(TRAP)

QY-E11743 96T
EUR 374

Pneumadin (rat) )

SP-100080-1 1 mg
EUR 286

SCF, rat

RC253-12 2ug
EUR 104.38
  • Product category: Proteins/Recombinant Proteins/Cytokines

VEGF165, rat

RC256-18 1mg
EUR 2364.2
  • Product category: Proteins/Recombinant Proteins/Growth Factors

CNTF, rat

RC258-19 5ug
EUR 104.38
  • Product category: Proteins/Recombinant Proteins/Neurotrophins

GDNF, rat

RC258-25 2ug
EUR 104.38
  • Product category: Proteins/Recombinant Proteins/Neurotrophins

CCL6, rat

RC355-17 2ug
EUR 101.33
  • Product category: Proteins/Recombinant Proteins/Cytokines

CCL11, rat

RC355-22 5ug
EUR 101.33
  • Product category: Proteins/Recombinant Proteins/Cytokines

MIF, rat

RC752-14 50ug
EUR 169.63
  • Product category: Proteins/Recombinant Proteins/Other

Rat anti Mouse(Rat) TNFRSF1A monoclonal antibody

CABT-L335 500ug
EUR 819

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-002 2ug
EUR 293

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-010 10ug
EUR 408

Recombinant Rat Apoliprotein-J (Clusterin Rat Recombinant)

CC015-101 1mg
EUR 6935

Liver Dissociation System 4 (Hepatocytes, rat), Rat

4-20304 ea Ask for price

Rat IgG2a (FITC) / Rat IgG2a (RPE) Isotype Control

abx405004-100tests 100 tests
EUR 634
  • Shipped within 1 week.

Pancreas Dissociation System 6 (Acinar, rat parotid), Rat

4-20376 ea Ask for price

CST3 Rat, Cystatin C Rat Recombinant Protein, sf9

PROTP14841-1 Regular: 10ug
EUR 317
Description: CST3 Rat Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 128 amino acids (21-140a.a.) and having a molecular mass of 14.3kDa (Molecular size on SDS-PAGE will appear at approximately 13.5-18kDa)._x000D_ CST3 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques

Rat SSA1 Protein

20-abx650878
  • EUR 578.00
  • EUR 258.00
  • EUR 1678.00
  • EUR 676.00
  • EUR 425.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat IL17C Protein

20-abx650879
  • EUR 704.00
  • EUR 286.00
  • EUR 2165.00
  • EUR 829.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat ABCC11 Protein

20-abx650881
  • EUR 690.00
  • EUR 286.00
  • EUR 2124.00
  • EUR 815.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat GTF3A Protein

20-abx650887
  • EUR 746.00
  • EUR 300.00
  • EUR 2332.00
  • EUR 885.00
  • EUR 523.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat CACNa1S Protein

20-abx650942
  • EUR 634.00
  • EUR 272.00
  • EUR 1901.00
  • EUR 746.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat CAPN11 Protein

20-abx650945
  • EUR 634.00
  • EUR 272.00
  • EUR 1901.00
  • EUR 746.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat CAPS2 Protein

20-abx650946
  • EUR 634.00
  • EUR 272.00
  • EUR 1901.00
  • EUR 746.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat CASC1 Protein

20-abx650948
  • EUR 634.00
  • EUR 272.00
  • EUR 1901.00
  • EUR 746.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat GRB14 Protein

20-abx650969
  • EUR 606.00
  • EUR 258.00
  • EUR 1817.00
  • EUR 718.00
  • EUR 439.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat TGFb3 Protein

20-abx650989
  • EUR 829.00
  • EUR 314.00
  • EUR 2666.00
  • EUR 996.00
  • EUR 578.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Rat THBS2 Protein

20-abx651005
  • EUR 704.00
  • EUR 286.00
  • EUR 2165.00
  • EUR 829.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

CRF (human, rat)

B5059-.5 500 µg
EUR 266

CRF (human, rat)

B5059-1 1 mg
EUR 460

Neuromedin U (rat)

B5231-1 1 mg
EUR 366

Neuromedin U (rat)

B5231-5 5 mg
EUR 1286

GLP-2 (rat)

B5282-.5 500 µg
EUR 242

GLP-2 (rat)

B5282-1 1 mg
EUR 416

Neuromedin S (rat)

B5466-.5 500 µg
EUR 466

Kisspeptin 10 (rat)

B5545-1 1 mg
EUR 324

Rat IGFBP-4

BP4CU015 15 µg
EUR 346

Rat IGFBP-5

BP5CU010 10 µg
EUR 253

/ Rat ELISA Kit

ELA-E0703r 96 Tests
EUR 886

/ Rat ELISA Kit

ELA-E1084r 96 Tests
EUR 886

GST/ Rat GST

ELA-E1090r 96 Tests
EUR 886

Ghrelin (mouse, rat)

H-4862.0500 0.5mg
EUR 515
Description: Sum Formula: C147H245N45O42; CAS# [258338-12-4] net

Ghrelin (mouse, rat)

H-4862.1000 1.0mg
EUR 877
Description: Sum Formula: C147H245N45O42; CAS# [258338-12-4] net

GLP-2 (rat)

H-5002.0500 0.5mg
EUR 273
Description: Sum Formula: C166H256N44O56S; CAS# [195262-56-7]

GLP-2 (rat)

H-5002.1000 1.0mg
EUR 466
Description: Sum Formula: C166H256N44O56S; CAS# [195262-56-7]

(Tyr0)-Urocortin (rat)

H-5486.0500 0.5mg
EUR 1167
Description: Sum Formula: C215H347N63O66; CAS# [187111-93-9]

Secretoneurin (mouse, rat)

H-5512.0500 0.5mg
EUR 347
Description: Sum Formula: C159H252N40O58; CAS# [149146-12-3] net

RFRP-3 (rat)

H-5846.0001 1.0mg
EUR 261
Description: Sum Formula: C88H134N26O25S2; CAS# [420088-80-8]

RFRP-3 (rat)

H-5846.0005 5.0mg
EUR 950
Description: Sum Formula: C88H134N26O25S2; CAS# [420088-80-8]

BNP-32 (rat)

H-5968.0500 0.5mg
EUR 599
Description: Sum Formula: C146H239N47O44S3; CAS# [133448-20-1] net

BNP-32 (rat)

H-5968.1000 1.0mg
EUR 1046
Description: Sum Formula: C146H239N47O44S3; CAS# [133448-20-1] net

Neuropeptide S (rat)

H-6164.0500 0.5mg
EUR 261
Description: Sum Formula: C95H160N34O27; CAS# [412938-75-1] net

Neuropeptide S (rat)

H-6164.1000 1.0mg
EUR 418
Description: Sum Formula: C95H160N34O27; CAS# [412938-75-1] net

Neuromedin S (rat)

H-6228.0500 0.5mg
EUR 454
Description: Sum Formula: C193H307N57O49S; CAS# [843782-19-4] net

Neuromedin S (rat)

H-6228.1000 1.0mg
EUR 696
Description: Sum Formula: C193H307N57O49S; CAS# [843782-19-4] net

Biotinyl-Obestatin (rat)

H-6362.0500 0.5mg
EUR 635
Description: Sum Formula: C124H188N36O33S; CAS# [1815618-11-1] net

Biotinyl-Obestatin (rat)

H-6362.1000 1.0mg
EUR 1059
Description: Sum Formula: C124H188N36O33S; CAS# [1815618-11-1] net

Cortistatin-29 (rat)

H-6444.0500 0.5mg
EUR 248
Description: Sum Formula: C161H240N46O41S2; CAS# [1815618-17-7] net

Cortistatin-29 (rat)

H-6444.1000 1.0mg
EUR 393
Description: Sum Formula: C161H240N46O41S2; CAS# [1815618-17-7] net

Nesfatin-1 (rat)

H-6472.0050 50.0µg
EUR 515
Description: Sum Formula: C424H684N116O136; CAS# [917528-37-1] net

Nesfatin-1 (rat)

H-6472.0250 250.0µg
EUR 1965
Description: Sum Formula: C424H684N116O136; CAS# [917528-37-1] net

Serpinin (mouse, rat)

H-6672.0500 0.5mg
EUR 334
Description: Sum Formula: C123H202N32O46; CAS# [1363332-88-0] net

Serpinin (mouse, rat)

H-6672.1000 1.0mg
EUR 576
Description: Sum Formula: C123H202N32O46; CAS# [1363332-88-0] net

Pancreatic Polypeptide (rat)

H-6890.0500 0.5mg
EUR 393
Description: Sum Formula: C195H298N58O57S; CAS# [90419-12-8]

Pancreatic Polypeptide (rat)

H-6890.1000 1.0mg
EUR 696
Description: Sum Formula: C195H298N58O57S; CAS# [90419-12-8]

Peptide Lv (rat)

H-7366.0100 0.1mg
EUR 360
Description: Sum Formula: C262H415N73O72S2; CAS# [1872441-58-1] net

Peptide Lv (rat)

H-7366.0500 0.5mg
EUR 1346
Description: Sum Formula: C262H415N73O72S2; CAS# [1872441-58-1] net

Galanin (mouse, rat)

H-7450.0500 0.5mg
EUR 334
Description: Sum Formula: C141H211N43O41; CAS# [114547-31-8]

CONCLUSIONS: In conclusion, our results have confirmed that DAAS insurance coverage has led to better clinical results than INF, which can reduce the increases in medical expenses and the risk of rehospital and functional disorders hepatic. What we know about this subject, interferon for hepatitis C has a low efficiency with serious side effects, while the effectiveness of new oral drugs (direct action antivirals, DAAS) is high. DAAs have been approved for a Taiwan registration in December 2013 and have been covered by national health insurance since January 2017. Little things are known about the proofs of the real world related to the DAA following the coverage of DAA In Taiwan, including the use of drugs, expenses and expenses. security.

Leave A Comment